CDKN2A and breast cancer: The identified hub genes—MYC, EGFR, CDKN2A, ERBB2, CDK1, E2F1, TOP2A, MDM2, TGFB1, and FOXM1—play significant roles in BC progression and are potential biomarkers for diagnosis, prognosis, and therapy.